Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies

Pathology. 2017 Aug;49(5):555-557. doi: 10.1016/j.pathol.2017.03.009. Epub 2017 Jul 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Cytomegalovirus / pathogenicity*
  • Cytomegalovirus Infections / chemically induced
  • Cytomegalovirus Infections / virology
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Diseases / pathology*
  • Gastrointestinal Diseases / virology
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell / virology
  • Male
  • Purines / adverse effects*
  • Purines / therapeutic use
  • Quinazolinones / adverse effects*
  • Quinazolinones / therapeutic use

Substances

  • Purines
  • Quinazolinones
  • idelalisib